Stocks

The table gives an overview of all stocks, alphabetically sorted.
 24SevenOffice Scandinavia AB 247 Jan 16, 2019 7.84 -5.31   
 2cureX AB 2CUREX Jan 16, 2019 17.80 -11.88   
 A Group Of Retail Assets Pref AGORAPREF Jan 16, 2019 268.00 0.00   
 A1M Pharma AB A1M Jan 16, 2019 1.29 +2.06   
 A3 Allmänna IT- och Telekom. AB ATRE Jan 16, 2019 13.70 -1.44   
 AAC Microtec AB AAC Jan 16, 2019 3.77 -0.79   
 AarhusKarlshamn AAK Jan 16, 2019 128.92 -0.19   
 ABB ABB Jan 16, 2019 172.00 -0.32   
 Abelco Investment Group ABIGMTF Jan 16, 2019 0.06 -1.75   
 Absolent Group AB ABSO Jan 16, 2019 242.00 -0.82   
 Absolicon Solar Collector AB ABSL Jan 16, 2019 115.00 0.00   
 AcadeMedia AB ACAD Jan 16, 2019 46.30 +5.35   
 Acando ACANB Jan 16, 2019 30.00 +1.69   
 Acarix AB ACARIX Jan 16, 2019 4.90 -3.16   
 Acconeer AB ACCON Jan 16, 2019 22.20 +3.26   
 Acosense AB ACOS Jan 16, 2019 3.30 -16.46   
 AcouSort ACOU Jan 16, 2019 8.99 +3.81   
 Acrinova AB ACRI Jan 16, 2019 45.00 0.00   
 Actic Group AB ATIC Jan 16, 2019 36.50 0.00   
 Active Biotech ACTI Jan 16, 2019 4.25 -3.30   
 AcuCort AB ACUC Jan 16, 2019 6.80 +3.66   
 AdCityMedia AB ACM Jan 16, 2019 113.00 -1.74   
 AdderaCare AB ADDERA Jan 16, 2019 5.56 +0.72   
 AddLife AB ALIFB Jan 16, 2019 230.00 -0.43   
 Addnode Group ANODB Jan 16, 2019 113.00 +1.35   
 Addtech B ADDTB Jan 16, 2019 167.40 +1.70   
 ADDvise Group AB ser. A ADDVA Jan 16, 2019 1.81 +38.02   
 ADDvise Group AB ser. B ADDVB Jan 16, 2019 0.80 -6.76   
 Advanced Stabilized Technologies Group ASTGMTFB Jan 16, 2019 0.06 0.00   
 Advenica AB ADVE Jan 16, 2019 4.40 +3.53   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK